Aptar’s core sales grew 5% year on year, while adjusted EBITDA margin fell 190 basis points to 21.3% from the prior year. Segment EBITDA margin for pharma, beauty, and closures declined 80, 70, and 60 basis points, respectively. Shares are up 5% from the previous day’s close on the news.
Aptar’s strong relationships with multinational customers will help the firm expand into emerging markets such as Asia and Latin America.
Aptar’s negotiating power could decline along with further consolidation of large consumer and pharmaceutical companies.
|
Metric
|
ATR
|
PODD
|
STVN
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.80 | 28.11 | 21.58 |
Price/Book Value | 3.56 | 7.25 | 2.03 |
Price/Sales | 2.38 | 3.62 | 2.53 |
Price/Cash Flow | 13.40 | 17.18 | 12.09 |
|
Metric
|
ATR
|
PODD
|
STVN
|
|---|---|---|---|
Quick Ratio | 0.90 | 1.56 | 1.18 |
Current Ratio | 1.50 | 2.51 | 1.73 |
Interest Coverage | 6.29 | 9.95 | 38.12 |
|
Metric
|
ATR
|
PODD
|
STVN
|
|---|---|---|---|
Return on Assets (Normalized) | 6.77% | 15.61% | 1.95% |
Return on Equity (Normalized) | 13.07% | 34.23% | 3.28% |
Return on Invested Capital (Normalized) | 9.42% | 21.82% | 2.67% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|TDd@<^t | LOCK|&@ | $170B | |||
| Becton Dickinson & Co
BDX
| LOCK|h?Y | LOCK|m?H?& | $57B | |||
| Alcon Inc
ALC
| LOCK|sQ?!&# | LOCK|Z!kc | $37B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|&s&D@XL | LOCK|h!^cN | $35B | |||
| ResMed Inc
RMD
| LOCK|MSrhz?V | LOCK|WgsS | $34B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|J?zw@K^! | LOCK|$B | $28B | |||
| Solventum Corp
SOLV
| LOCK|^>S<>$ | LOCK|G?C | $15B | |||
| Baxter International Inc
BAX
| LOCK|<< | LOCK|VpxQD | $14B | |||
| The Cooper Companies Inc
COO
| LOCK|P!%BRy> | LOCK|J?&KY | $12B | |||
| Align Technology Inc
ALGN
| LOCK|g$Fb?k | LOCK|!Dcl | $12B |
United States